UBS AM
GEN

UBS AM’s Genesis Healthcare, Inc. GEN Stock Holding History

UBS AM’s Portfolio GEN Stock Details GEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-39,900
Closed -$46.3K – 2619
2017
Q3 		$46.3K Hold
39,900
– – ﹤0.01% 2404
2017
Q2 		$69.4K Buy
39,900
+26,100
+189% +$55.5K ﹤0.01% 2371
2017
Q1 		$36.4K Hold
13,800
– – ﹤0.01% 2363
2016
Q4 		$59K Hold
13,800
– – ﹤0.01% 2297
2016
Q3 		$37K Hold
13,800
– – ﹤0.01% 2591
2016
Q2 		$24K Hold
13,800
– – ﹤0.01% 2606
2016
Q1 		$32K Hold
13,800
– – ﹤0.01% 2622
2015
Q4 		$48K Buy
+13,800
New +$66.1K ﹤0.01% 2685

Other funds holding GEN

CPA
Columbia Pacific Advisors Seattle, Washington $31M AUM 29.53% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
FWC
First Washington Corp Seattle, Washington $353M AUM 41.46% 1-Year Est. Return
PGCM
Prescott Group Capital Management Tulsa, Oklahoma $1B AUM 51.95% 1-Year Est. Return
VCM
V3 Capital Management Dallas, Texas $33.4M AUM 5.9% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS AM's GEN Position: Q4 2017 in Review

UBS AM sold out of Genesis Healthcare, Inc. (GEN) in Q4 2017, closing a stake of 39,900 shares — an estimated $46.3K sold.

UBS AM first reported a position in GEN in Q4 2015 and held it in 8 quarters. The position peaked at $69.4K in Q2 2017. 68 funds tracked by Wall St. Rank hold GEN as of Q4 2017.

  • UBS AM reported no remaining Genesis Healthcare, Inc. position as of Q4 2017 after selling out during the quarter.
  • UBS AM sold 39,900 Genesis Healthcare, Inc. shares in Q4 2017, an estimated $46.3K.
  • UBS AM first reported a position in Genesis Healthcare, Inc. in Q4 2015 and held it in 8 quarters.
  • UBS AM's Genesis Healthcare, Inc. position peaked at $69.4K in Q2 2017.
  • 68 funds tracked by Wall St. Rank held Genesis Healthcare, Inc. as of Q4 2017.

Based on UBS AM's 13F filing for Q4 2017, filed 9 Feb 2018.